Regulation of oxygen utilization by angiotensin II in chronic kidney disease

Leichtweiss, 1969, The oxygen supply of the rat kidney: measurements of int4arenal pO2, Pflugers Arch, 309, 328, 10.1007/BF00587756 Schurek, 1990, Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex, Am J Physiol, 259, F910 Welch, 2001, Nephron pO2 and renal oxygen usage in the hypertensive rat kidney, Kidney Int, 59, 230, 10.1046/j.1523-1755.2001.00483.x Nangaku, 2006, Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure, J Am Soc Nephrol, 17, 17, 10.1681/ASN.2005070757 Deng, 2005, Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II, Kidney Int, 68, 723, 10.1111/j.1523-1755.2005.00450.x Laycock, 1998, Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney, Circ Res, 82, 1263, 10.1161/01.RES.82.12.1263 Welch, 2005, Angiotensin-induced defects in renal oxygenation: role of oxidative stress, Am J Physiol Heart Circ Physiol, 288, H22, 10.1152/ajpheart.00626.2004 Harris, 1988, Remnant kidney hypermetabolism and progression of chronic renal failure, Am J Physiol, 254, F267 Nath, 1990, Oxygen consumption and oxidant stress in surviving nephrons, Am J Physiol, 258, F1354 Manotham, 2004, Evidence of tubular hypoxia in the early phase in the remnant kidney model, J Am Soc Nephrol, 15, 1277, 10.1097/01.ASN.0000125614.35046.10 Norman, 2006, Intrarenal oxygenation in chronic renal failure, Clin Exp Pharmacol Physiol, 33, 989, 10.1111/j.1440-1681.2006.04476.x Baylis, 2008, Nitric oxide deficiency in chronic kidney disease, Am J Physiol Renal Physiol, 294, F1, 10.1152/ajprenal.00424.2007 Roczniak, 1999, Downregulation of neuronal nitric oxide synthase in the rat remnant kidney, J Am Soc Nephrol, 10, 704, 10.1681/ASN.V104704 Mackie, 2001, Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency, Kidney Int, 59, 1458, 10.1046/j.1523-1755.2001.0590041458.x Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl J Med, 345, 861, 10.1056/NEJMoa011161 de Zeeuw, 2004, Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL, Kidney Int, 65, 2309, 10.1111/j.1523-1755.2004.00653.x Fujihara, 2005, An extremely high dose of losartan affords superior renoprotection in the remnant model, Kidney Int, 67, 1913, 10.1111/j.1523-1755.2005.00290.x Lewis, 1993, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004 Lewis, 2001, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes, N Engl J Med, 345, 851, 10.1056/NEJMoa011303 Szabo, 2003, Renal neuronal nitric oxide synthase protein expression as a marker of renal injury, Kidney Int, 64, 1765, 10.1046/j.1523-1755.2003.00260.x Elfering, 2002, Biochemistry of mitochondrial nitric-oxide synthase, J Biol Chem, 277, 38079, 10.1074/jbc.M205256200 Ghafourifar, 2005, Mitochondrial nitric oxide synthase, Trends Pharmacol Sci, 26, 190, 10.1016/j.tips.2005.02.005 Gill, 2006, NADPH oxidases in the kidney, Antioxid Redox Signal, 8, 1597, 10.1089/ars.2006.8.1597 Vaziri, 2003, Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency, Kidney Int, 63, 179, 10.1046/j.1523-1755.2003.00702.x Needleman, 1986, Arachidonic acid metabolism, Annu Rev Biochem, 55, 69, 10.1146/annurev.bi.55.070186.000441 Borutaite, 1996, Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide, Biochem J, 315, 295, 10.1042/bj3150295 Brown, 1994, Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase, FEBS Lett, 356, 295, 10.1016/0014-5793(94)01290-3 Cleeter, 1994, Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases, FEBS Lett, 345, 50, 10.1016/0014-5793(94)00424-2 Andersson, 1998, Inactivation of aconitase and oxoglutarate dehydrogenase in skeletal muscle in vitro by superoxide anions and/or nitric oxide, Biochem Biophys Res Commun, 249, 512, 10.1006/bbrc.1998.9171 Brown, 2001, Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase, Biochim Biophys Acta, 1504, 46, 10.1016/S0005-2728(00)00238-3 Brown, 2002, Nitric oxide inhibition of mitochondrial respiration and its role in cell death, Free Radic Biol Med, 33, 1440, 10.1016/S0891-5849(02)01112-7 Brown, 2004, Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols, Biochim Biophys Acta, 1658, 44, 10.1016/j.bbabio.2004.03.016 Ramachandran, 2004, Chronic exposure to nitric oxide alters the free iron pool in endothelial cells: role of mitochondrial respiratory complexes and heat shock proteins, Proc Natl Acad Sci USA, 101, 384, 10.1073/pnas.0304653101 Ghafourifar, 1997, Nitric oxide synthase activity in mitochondria, FEBS Lett, 418, 291, 10.1016/S0014-5793(97)01397-5 Giulivi, 1998, Production of nitric oxide by mitochondria, J Biol Chem, 273, 11038, 10.1074/jbc.273.18.11038 Riobo, 2002, The modulation of mitochondrial nitric-oxide synthase activity in rat brain development, J Biol Chem, 277, 42447, 10.1074/jbc.M204580200 Boveris, 2003, Kidney mitochondrial nitric oxide synthase, Antioxid Redox Signal, 5, 265, 10.1089/152308603322110841 Kanai, 2001, Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection, Proc Natl Acad Sci USA, 98, 14126, 10.1073/pnas.241380298 Koivisto, 1999, Oxygen-dependent inhibition of respiration in isolated renal tubules by nitric oxide, Kidney Int, 55, 2368, 10.1046/j.1523-1755.1999.00474.x Bosse, 1995, Parallel regulation of constitutive NO synthase and renin at JGA of rat kidney under various stimuli, Am J Physiol, 269, F793 Shultz, 1993, Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide, J Clin Invest, 91, 642, 10.1172/JCI116244 Chen, 2007, Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II, J Vasc Res, 44, 391, 10.1159/000103284 Hasegawa, 2007, Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2, Circ Res, 101, e2, 10.1161/CIRCRESAHA.107.156901 Matsuguma, 2006, Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease, J Am Soc Nephrol, 17, 2176, 10.1681/ASN.2005121379